Contact us
Schedule a Demo

CPT Code 43254 Complete Billing & Coding Guide for Endoscopic Mucosal Resection (EMR)

best medical billing company

Seamless Global Period Tracking and Compliance

Accurate OB Contract Management and Patient Collections

Advanced upper endoscopy procedures with the removal of superficial gastrointestinal lesions are commonly reported using a CPT code of 43254 (Endoscopic mucosal resection (EMR) of superficial gastrointestinal lesions). In order to ensure accurate coding, there is a need for clear documentation of the characteristics of the lesion, technique of resection done and medical necessity for the procedure. 

The mucosal resection process should be well documented during EMR, which is more extensive than standard snare polypectomy, and techniques that will aid in lesion removal should be noted. Compliance in billing is aided by proper documentation, as is the avoidance of delays or denials in reimbursement. 

CPT 43254 Description

Official Definition:
"Esophagogastroduodenoscopy, flexible, transoral; with endoscopic mucosal resection."

CPT 43254 describes a therapeutic upper gastrointestinal endoscopy in which a flexible endoscope is advanced through the mouth to examine the esophagus, stomach, and duodenum. During the procedure, the physician performs endoscopic mucosal resection (EMR) to remove superficial lesions, including precancerous, dysplastic, or early-stage malignant tissue.

EMR typically involves lifting the lesion through submucosal injection followed by resection using a snare or other specialized endoscopic techniques. The diagnostic EGD component is included in the procedure and should not be reported separately.

The service includes

  • Flexible transoral esophagogastroduodenoscopy (EGD)
  • Examination of the esophagus, stomach, and duodenum
  • Endoscopic mucosal resection (EMR)
  • Directed submucosal injection when performed for the same lesion
  • Snare resection of the targeted lesion
  • Endoscopic band ligation used as part of the EMR technique
  • Assessment of the resection site following removal

CPT 43254 does not include

  • Separate reporting of the diagnostic EGD
  • Simple tissue biopsy
  • Standard snare polypectomy, without EMR.
  • Endoscopic submucosal dissection (ESD)
  • Separate billing for moderate sedation when included under payer guidelines 

Clinical Indications for CPT 43254

CPT 43254 is generally reported when the gastrointestinal lesions are superficial and need to be removed with an advanced endoscope. It is frequently carried out to avoid surgery and treat early or precancerous lesions. 

Common indications include

  • Esophagus lined by Barrett's epithelium and with dysplasia. 
  • Early-stage esophageal cancer
  • Early gastric neoplasms
  • Early duodenal neoplasms
  • Large flat gastrointestinal lesions
  • Laterally spreading lesions
  • Superficial mucosal tumors
  • Precancerous gastrointestinal lesions requiring complete resection

The procedure may also be used for staging and therapeutic management of selected mucosal abnormalities identified during diagnostic evaluation.

Reimbursement Insights for CPT 43254

Reimbursement for CPT 43254 is generally higher than diagnostic EGD and standard lesion removal procedures because of the advanced therapeutic work involved. Proper documentation should clearly support the need for mucosal resection and distinguish the service from standard snare excision procedures.

Key reimbursement considerations

  • Medically necessary it will be covered by Medicare and most commercial payers.
  • Reimbursement is usually greater than diagnostic EGD and routine polypectomy. 
  • Global period: 000 days
  • Diagnostic EGD is bundled into CPT 43254
  • Submucosal injection and lesion removal performed as part of the same EMR are included
  • Payment varies based on payer contracts, geographic location, and site of service
  • Hospital outpatient departments and ASCs may receive separate facility reimbursement
  • Incomplete documentation of EMR technique may increase denial risk

Applicable Modifiers for CPT 43254

Modifier usage should accurately reflect procedural circumstances and any additional services performed during the encounter. Documentation must support all modifiers submitted on the claim.

Common modifiers

  • Modifier -51: When more than one procedure is performed during the same operative session. 
  • Modifier -59 or X{EPSU}: Used for a distinct procedural service performed at a separate anatomical site or by different methods. 
  • Modifier -22: Used when the procedure requires substantially greater work than typically required, supported by detailed documentation.
  • Modifier -52: Used when the planned procedure is partially reduced.
  • Modifier -53: Used when the procedure is discontinued due to patient safety concerns or technical limitations.
  • Modifier -78: Used for an unplanned return to the procedure room during the postoperative period for a related procedure.
  • Modifier -79: Used when an unrelated procedure is performed during the postoperative period.

Important billing rule

CPT 43254 includes the diagnostic EGD component and should not be reported with CPT 43235 during the same session.

Documentation Requirements for CPT 43254

Operative report should clearly show that the procedure was endoscopic mucosal resection, not just a snare. 

Documentation should include

  • A medical reason for the procedure. 
  • Lesion location
  • The amount and nature of the lesions 
  • The presence of mucosal involvement 
  • EMR technique utilized
  • Submucosal injection details when carried out by a trained practitioner. 
  • Resection method used
  • En-bloc or piecemeal removal documentation
  • Completeness of resection
  • Specimen retrieval details
  • Any procedural complications
  • The patient's acceptance of the procedure.
  • Final procedure report, with signature. 

Clear documentation of the EMR technique is critical for distinguishing CPT 43254 from CPT 43251 and other upper GI lesion removal procedures.

Example Clinical Scenarios

Scenario 1: Barrett's Esophagus With High-Grade Dysplasia

When surveillance biopsies show high grade dysplasia, the patient with Barrett's esophagus has an upper endoscopy. The physician makes a submucosal injection and then resects the dysplastic tissue with EMR.

Coding Outcome: CPT 43254

Rationale: Endoscopic mucosal resection was performed to remove dysplastic mucosal tissue during EGD.

Scenario 2: Large Gastric Lesion Requiring EMR

A 68-year-old patient presents with a large superficial gastric lesion identified during previous endoscopic evaluation. The lesion is lifted with submucosal injection and removed using an EMR technique.

Coding Outcome: CPT 43254

Rationale: The lesion was removed using endoscopic mucosal resection rather than standard snare polypectomy.

Scenario 3: Early Duodenal Neoplasm Treated Endoscopically

EGD is performed in a patient to assess a superficial neoplasm of the duodenum. Endoscopic mucosal resection with complete removal of lesion and specimen retrieval is performed by the doctor. 

Coding Outcome: CPT 43254

Rationale: Therapeutic EMR was carried out for complete removal of a superficial lesion in the duodenum. 

Scenario 4: Procedure Discontinued Due to Bleeding Risk

A large esophageal lesion is planned for EMR. After partial resection, there is a significant risk of bleeding, and the doctor decides not to continue the procedure for the patient's safety. 

Coding Outcome: CPT 43254-53

Rationale: The procedure was not completed because of safety concerns for the patient, supporting modifier -53. 

BillingFreedom Helping GI Practices Achieve 95%+ Clean Claim Accuracy

BillingFreedom helps support gastroenterology practices in achieving more accurate coding of advanced endoscopic procedures with complex documentation requirements. For services like EMR, there must be reporting of procedures, descriptions of the lesions, and the proper technique.

Our team coordinates with providers to work out documentation deficiencies prior to claim submission, which helps to minimize coding inaccuracies and unnecessary claim delays. Structured claim review and coding oversight supports practices to improve gastroenterology medical billing performance in high complexity, GI procedures. 

Key Performance Indicators We Continuously Monitor

  • 97% – 99% of claims accepted in the first pass
  • The frequency of claims denied that could have been prevented is less than 1%.
  • Recordly, the claim submission accuracy is over 95% clean.
  • High accuracy of coding validation of approximately 98% on internal validation
  • Regular quality checks of documentation to minimise claim corrections and rework. 

Practices interested in learning more about coding compliance, documentation standards, and reimbursement workflows can explore educational resources related to Gastroenterology Billing Services for additional industry insights.

For more details about our best Gastroenterology medical billing services, please don't hesitate to contact us by email at info@billingfreedom.com or call us at +1 (855) 415-3472. 

It is our top priority to give you financial peace of mind!